No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
PETQ PetIQ
- 22.210
- +0.160+0.73%
Close Jun 18 16:00 ET
- 22.210
- 0.0000.00%
Post 16:18 ET
655.65MMarket Cap96.57P/E (TTM)
22.430High22.040Low213.49KVolume22.050Open22.050Pre Close4.74MTurnover0.83%Turnover Ratio317.29P/E (Static)29.52MShares22.98052wk High2.78P/B570.64MFloat Cap14.20052wk Low--Dividend TTM25.69MShs Float46.000Historical High--Div YieldTTM1.77%Amplitude6.660Historical Low22.220Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
PetIQ(PETQ.US) Director Sells US$268.88K in Common Stock
$PetIQ(PETQ.US)$ Director Huff Scott sold 12,117 shares of common stock on Jun 12, 2024 at an average price of $22.19 for a total value of $268.88K.Source: Announcement What is statement of changes in
PetIQ, Inc. to Participate in the Oppenheimer 24th Annual Consumer Growth and E-Commerce Conference
EAGLE, Idaho, June 05, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. ("PetIQ" or the "Company") (NASDAQ:PETQ), a leading pet medication, product and wellness company, today announced that members of its executive management
Wall Street Analysts See a 40.44% Upside in PetIQ (PETQ): Can the Stock Really Move This High?
Shareholders Will Probably Hold Off On Increasing PetIQ, Inc.'s (NASDAQ:PETQ) CEO Compensation For The Time Being
Key Insights PetIQ's Annual General Meeting to take place on 7th of June Total pay for CEO Cord Christensen includes US$1.05m salary The overall pay is 69% above the industry average PetIQ's EP
Shareholders Will Be Pleased With The Quality of PetIQ's (NASDAQ:PETQ) Earnings
PetIQ, Inc. (NASDAQ:PETQ) recently posted some strong earnings, and the market responded positively. Our analysis found some more factors that we think are good for shareholders. NasdaqGS:PETQ Ear
Wall Street Analysts See a 45.22% Upside in PetIQ (PETQ): Can the Stock Really Move This High?
Comments
Market expectations of PetIQ's future revenue decline could be suppressing the P/S ratio. With a lower growth forecast than the industry, it's understandable that PetIQ's P/S is below most companies. A strong share price rise seems unlikely under these circumstances.
Investors Don't See Light At End Of PetIQ, Inc.'s (NASDAQ:PETQ) Tunnel 1
Jefferies' analysts have faith in both Chewy and PetIQ as they are shielded from increasing pet care costs due to their strategic positions and target customer demographics. Expectations are high for Chewy's expansion in pet health and elsewhere, while PetIQ stands to gain from a rising focus on preventative pet health.
1
1
Both PetIQ's accrual ratio and its unusual items suggest that its statutory earnings are possibly conservative. Its potential to increase profit if unusual items do not reoccur indicates a hopeful future outlook.
Gainers:
In reaction to earnings/guidance:
• $The Trade Desk(TTD.US$+17%, $Workiva(WK.US$ +15.3%, $Arlo Technologies(ARLO.US$ +12%, $Array Technologies(ARRY.US$ +10.3%, $Everbridge(EVBG.US$ +9.7%, $Catalyst Pharmaceuticals(CPRX.US$ +9.4%, $Halozyme Therapeutics(HALO.US$ +8.7%, $Velo3D(VLD.US$ +7.6%, $CyberArk(CYBR.US$ + 6.2%, $Haemonetics(HAE.US$ +5.8%, $Jackson Financial(JXN.US$ +5.7% (also increases dividend), $Axon Enterprise(AXON.US$ +4.8%, ...
In reaction to earnings/guidance:
• $The Trade Desk(TTD.US$+17%, $Workiva(WK.US$ +15.3%, $Arlo Technologies(ARLO.US$ +12%, $Array Technologies(ARRY.US$ +10.3%, $Everbridge(EVBG.US$ +9.7%, $Catalyst Pharmaceuticals(CPRX.US$ +9.4%, $Halozyme Therapeutics(HALO.US$ +8.7%, $Velo3D(VLD.US$ +7.6%, $CyberArk(CYBR.US$ + 6.2%, $Haemonetics(HAE.US$ +5.8%, $Jackson Financial(JXN.US$ +5.7% (also increases dividend), $Axon Enterprise(AXON.US$ +4.8%, ...
11
2
CAN I AT LEAST LEAST LEATHER HOW TO BUY N SELL STOCKS ON THIS BROCHURE MOOMOO 
FOR REAL I DONT GET IT 
Gainers：
• $Affirm Holdings(AFRM.US$ +36.4% (also announces multi-year extension of exclusive partnership with SHOP in the US)
• $Robinhood(HOOD.US$ +22.9% (Emergent Fidelity discloses 7.6% stake; Sam Bankman-Fried CEO of crypto exchange FTX is majority holder in fund)
• $Endeavor Group(EDR.US$ +20% (in reaction to earnings)
• $Coinbase(COIN.US$ +13% (in sympathy with HOOD news)
• $Dynavax Technologies(DVAX.US$ +11.5% (to join ...
• $Affirm Holdings(AFRM.US$ +36.4% (also announces multi-year extension of exclusive partnership with SHOP in the US)
• $Robinhood(HOOD.US$ +22.9% (Emergent Fidelity discloses 7.6% stake; Sam Bankman-Fried CEO of crypto exchange FTX is majority holder in fund)
• $Endeavor Group(EDR.US$ +20% (in reaction to earnings)
• $Coinbase(COIN.US$ +13% (in sympathy with HOOD news)
• $Dynavax Technologies(DVAX.US$ +11.5% (to join ...
27
2
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg